Pemetrexed Plus Lenalidomide for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Prospective Single-Arm Phase II Study

The prognosis of relapsed/refractory (R/R) primary central nervous system lymphoma (PCNSL) is dismal, and there are limited treatment options for these patients. This was a prospective single-arm phase II study of combined pemetrexed and lenalidomide for salvage treatment of R/R PCNSL. Patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jingjing, Lin, Zhiguang, Ding, Tianling, Li, Qing, Zhang, Mengxue, Kang, Hui, Johnston, Patrick B., Ma, Yan, Chen, Bobin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309305/
https://www.ncbi.nlm.nih.gov/pubmed/35898888
http://dx.doi.org/10.3389/fonc.2022.938421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309305/
https://www.ncbi.nlm.nih.gov/pubmed/35898888
http://dx.doi.org/10.3389/fonc.2022.938421

Ejemplares similares